Results 201 to 210 of about 19,083 (252)

Pulmonary Disease Due to Antirheumatic Agents

Clinics in Chest Medicine, 1990
Drug-induced lung disease presents several diagnostic and therapeutic problems to the clinician. This is especially true in the case of lung disease associated with antirheumatic agents in which pulmonary disease may be due to the underlying disorder.
R J, Zitnik, J A, Cooper
exaly   +3 more sources

Safe Use of Antirheumatic Agents in Patients with Comorbidities

Rheumatic Disease Clinics of North America, 2012
The burden of comorbid diseases is high among patients with rheumatoid arthritis (RA). These are often systemic manifestations of RA but may be chronic conditions that predate or develop post-RA diagnosis. Increased mortality in RA is predominantly from nonarticular causes.
Ashima Mąkol
exaly   +3 more sources

Antirheumatic agents and leukocyte recruitment

Biochemical Pharmacology, 1999
Michael J Parnham
exaly   +2 more sources

Therapeutics of antirheumatic agents.

American journal of hospital pharmacy, 1980
Eric Boyce, Ronald P. Evens
core   +4 more sources

New Antirheumatic Agents

JAMA - Journal of the American Medical Association, 1977
John R Lewis
exaly   +2 more sources

A controlled study of chloroquine as an antirheumatic agent

Arthritis & Rheumatism, 1958
AbstractThe use of a double‐blind therapeutic study to determine the effects of chloroquine on rheumatoid arthritis demonstrated antirheumatic properties of this drug. The criteria of Lansbury were successfully combined with other objective measurements to provide data of statistical validity.
A S, COHEN, E, CALKINS
openaire   +2 more sources

Zyn-Linker delivery of antirheumatic agents

Immunologic Research, 1994
Despite our increasing ability to manage rheumatoid arthritis through systemic medication, refractory joints require local administration of more aggressive therapy in a substantial number of patients. These studies tested whether a new class of molecules designated Zyn-Linkers could deliver and retain therapeutics in a joint. Zyn-Linkers are synthetic
B M, Ohlsson-Wilhelm, M R, McDevitt, B D, Gray, R, Lorinc, H B, McIlvain, K, Sheth, S A, Weeks, K A, Muirhead   +7 more
openaire   +2 more sources

Drug therapy reviews: Antirheumatic agents

American Journal of Health-System Pharmacy, 1979
The pathophysiology, symptoms and drug treatment of rheumatic disease are reviewed. Antirheumatic drugs reviewed are salicylates (including aspirin, sodium salicylate, choline salicylate, choline magnesium salicylate, salsalate), phenylpropionic acid derivatives (fenoprofen, ibuprofen, naproxen), indole derivatives (sulindac, tolmetin and indomethacin),
openaire   +2 more sources

Articular Pharmacokinetics of Protein-Bound Antirheumatic Agents

Clinical Pharmacokinetics, 1993
By what mechanism do nonsteroidal anti-inflammatory drugs (NSAIDs) move from plasma into synovial fluid and back, and how does binding to plasma albumin in vitro relate to articular transport in vivo? To evaluate these issues, concurrent plasma and synovial fluid data of 8 different NSAIDs from 10 single-dose trials were analysed by a simple ...
P A, Simkin, M P, Wu, D M, Foster
openaire   +2 more sources

[Nonsteroid antirheumatic agents].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977
It is given a short, oriented to practice survey on the at present internationally most usual non-steroidal antirheumatic drugs. Picture of effect and efficiency, side-effects, indications and contraindications of these remedies are described and compared.
openaire   +1 more source